Harmony and regulation yield to the need for payment
This article was originally published in Clinica
Executive Summary
Reimbursement, with its prosaic consequences - making a profit that justifies investment, keeps the company afloat and employees employed - has now quite definitely taken the place of regulatory issues as the topic most often at the top of the world medical device and diagnostics industries' agendas. As Clinica predicted last year: the issue of reimbursement is here to stay.